Mirta Dumančić

Title: Mirta Dumančić: Innovator in Radiation Therapy

Introduction

Mirta Dumančić is a prominent inventor based in Beer Sheva, Israel. She has made significant contributions to the field of medical technology, particularly in cancer treatment. Her innovative approach focuses on utilizing radiation therapy to improve patient outcomes.

Latest Patents

Dumančić holds a patent for a groundbreaking method titled "Diffusing alpha-emitter radiation therapy for prostate cancer." This method involves identifying a tumor as a prostate cancer tumor and implanting at least one diffusing alpha-emitter radiation therapy (DaRT) source within the tumor. The DaRT source is designed to release radon at a specific rate, providing a cumulated activity of released radon between 7 Mega becquerel (MBq) hour and 14.7 MBq hour per centimeter length. Each DaRT source is strategically placed less than 3.9 millimeters apart from adjacent sources, enhancing the effectiveness of the treatment.

Career Highlights

Dumančić is associated with Alpha Tau Medical Ltd., a company dedicated to advancing cancer treatment technologies. Her work has positioned her as a key figure in the development of innovative therapies that aim to improve the quality of life for patients suffering from prostate cancer.

Collaborations

Throughout her career, Dumančić has collaborated with notable professionals in her field, including Itzhak Kelson and Yona Keisari. These partnerships have contributed to the advancement of her research and the successful implementation of her patented technologies.

Conclusion

Mirta Dumančić's contributions to radiation therapy represent a significant advancement in the fight against prostate cancer. Her innovative methods and collaborations continue to pave the way for improved treatment options for patients.